Human recombinant interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a double-blind, international, phase 2, randomized, placebo-controlled trial - the PREV-HAP study - Nantes University Hospital
clinicaltrials.gov; 2021 Mar [cited 2021 Aug 12]. Report No.: NCT04793568. Available at: